Concepedia

Tatiana Shimonova

TS

4

Publications

203

Citations

4

H-Index

2017

Active since

Affiliations

Infectious Clinical Hospital No. 1(Current)

Assistance Publique – Hôpitaux de Paris

Tatiana Shimonova is an author at Infectious Clinical Hospital No. 1 specializing in medicine, epidemiology, and hepatitis c.

Top concepts

MedicineHivVirologyHepatitisHepatologyHepatitis CEpidemiologyClinical TrialsPharmacotherapyViral Hepatitis

Publications per year

2017–2023

4

Publications

4

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study

Jürgen K. Rockstroh, Karine Lacombe, Rolando M. Viani et al. · Clinical Infectious Diseases · 2018 · 144 citations · Full text

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

Chloe Orkin, Jean‐Michel Molina, Pedro Cahn et al. · The Lancet HIV · 2023 · 25 citations · Full text

First-line Therapy, Open-label Extensions, Antiviral Drug Development +7

Efficacy and safety of Glecaprevir/Pibrentasvir in patients co-infected with hepatitis C virus and human immunodeficiency virus-1: the EXPEDITION-2 Study

JK Rockstroh, Karine Lacombe, Rolando M. Viani et al. · Journal of Hepatology · 2017 · 24 citations

Hepatology, Hepatitis C, Hepatitis C Virus +12

Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study

Elena Orlova‐Morozova, Tatiana Shimonova, Nataliya Zaharova et al. · Journal Infectology · 2018 · 10 citations · Full text

Rows per page

1–4 of 4